FreeGulliver LLC’s Eli Lilly LLY Stock Holding History

FreeGulliver LLC’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$685K	Sell	571 -71	-11%	-$72.5K	0.24%	47
2026 Q1	$590K	Buy	642 +25	+4%	+$25.3K	0.25%	47
2025 Q4	$663K	Buy	617 +153	+33%	+$146K	0.24%	45
2025 Q3	$354K	Buy	+464	New	+$345K	0.16%	65
2025 Q2	–	Sell	-122	Closed	-$101K	–	92
2025 Q1	$101K	Sell	122 -185	-60%	-$154K	0.05%	93
2024 Q4	$237K	Buy	307 +47	+18%	+$38.9K	0.11%	80
2024 Q3	$230K	Buy	+260	New	+$234K	0.14%	73

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FreeGulliver LLC's LLY Position: Q2 2026 in Review

FreeGulliver LLC reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $72.5K and leaving 571 shares worth $685K. The position accounts for 0.24% of the portfolio, ranked #47.

FreeGulliver LLC first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

FreeGulliver LLC held 571 shares of Eli Lilly worth $685K as of Q2 2026.
FreeGulliver LLC sold 71 Eli Lilly shares in Q2 2026, an estimated $72.5K.
Eli Lilly made up 0.24% of FreeGulliver LLC's portfolio in Q2 2026, its #47 holding.
FreeGulliver LLC first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FreeGulliver LLC's 13F filing for Q2 2026, filed 11 Aug 2026.